Hormone Therapy News

Later natural menopause and a longer reproductive span may provide positive effects on trabecular volumetric bone mineral density into early old age.

In the United States, general practitioners and obstetrician/gynecologists are more likely to prescribe FDA-approved hormone therapy, whereas wellness practitioners are more likely to prescribe compounded hormone therapy, according to recent survey data.

In postmenopausal women with moderate to severe vulvar and vaginal atrophy, a vaginal softgel suppository containing estradiol was a safe and effective treatment option and yielded lower systemic estrogen absorption compared with currently available intravaginal treatments, study results show.

Adult patients with severe growth hormone deficiency previously treated for acromegaly saw an increased fracture risk after 6 years of growth hormone replacement therapy, whereas those previously treated for Cushing’s disease did not experience the same risk, according to a recent observational study.

In girls who experience moderately early puberty, gonadotropin-releasing human analogue treatment had no effect on final height, according to study findings published in the Journal of Clinical Research in Pediatric Endocrinology.

In some women with polycystic ovary syndrome, smaller adrenal volumes and higher steroid hormone secretion after dexamethasone therapy were detected, according to study results.

Testosterone therapy consistently improved most types of sexual activity in symptomatic older men with low testosterone levels.

In women with spontaneous premature ovarian failure, hormone therapy was shown to increase bone density at the lumbar spine at a greater rate vs. combined oral contraceptives or no treatment, recent study findings show.

Vasomotor symptoms in men with hypogonadism may be mediated be estradiol deficiency and high levels of testosterone may suppress the effects, according to study findings published in The Journal of Clinical Endocrinology & Metabolism.

Italian adults with Prader-Willi syndrome and obesity are at increased risk for altered glucose metabolism as they get older, when the frequency of overweight and obesity is higher, according to recent study findings.